Skip to content
DraconiticResearch
Search Sources API
194,220 studies31 sourcesUpdated 16 min ago
PreprintCC BY-NC-NDmedRxiv

PCR Detection and Species Identification of Leishmania in Microscopy-Negative Smears from Suspected Cutaneous Leishmaniasis in Iran

  1. 1Mazandaran University of Medical Sciences

Abstract

BackgroundDirect microscopy remains a practical first-line test for cutaneous leishmaniasis (CL), but it can miss infections when parasite numbers are low or lesions are chronic. We evaluated whether PCR could detect and identify Leishmania in Giemsa-stained smears that had already been reported as microscopy-negative.

MethodsWe retrospectively analyzed 131 microscopy-negative smears from patients with clinically suspected CL who attended health-center laboratories in Gonbad-e-Qabus and Torbat-e-Jam, Iran, between March 2013 and February 2015. DNA was recovered from the stained slides by phenol-chloroform-isoamyl alcohol extraction. kDNA PCR was used for molecular detection and species identification.

ResultsLeishmania DNA was detected in 34 of 131 microscopy-negative samples (25.9%; exact 95% CI, 18.7%-34.3%). Twenty-three positive samples (67.6%) were identified as L. major and 11 (32.4%) as L. tropica. All L. major-positive samples came from Gonbad-e-Qabus, whereas all L. tropica-positive samples came from Torbat-e-Jam. Most PCR-positive lesions (27/34, 79.4%) were chronic, secondarily infected, and/or clinically atypical. In a small laboratory verification panel, all 10 microscopy-positive smears were PCR-positive and all 10 non-leishmanial dermatosis controls were PCR-negative.

ConclusionsAbout one in four clinically suspected cases with a negative smear still had detectable Leishmania DNA. PCR of previously stained slides can therefore provide useful second-line confirmation and species information, especially when lesions are chronic or atypical. The small control panel supports assay performance in the study laboratory but is not large enough to provide precise estimates of clinical sensitivity or specificity.

Related

  1. Urine-based detection of Leishmania donovani antibodies using recombinant aurora kinase and otubain cysteine peptidase for noninvasive diagnosis of visceral leishmaniasis
    Anirban Bhattacharyya, Mohd Kamran, Rudra Chhajer +8
    Journal of Clinical MicrobiologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  2. Nano-Based Sodium Stibogluconate for Treatment of Cutaneous Leishmaniasis Caused by Leishmania major in Male Mice.
    Zahra A Alamri, Noha T Zelai, Amaal H Hassan
    Journal of parasitology researchPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  3. Topical Cotton Boll Extract as an Adjunct to Standard Pentavalent Antimonial Therapy in Cutaneous Leishmaniasis Caused by Leishmania tropica: A Randomized Pilot Clinical Trial.
    Mehdi Shafiei Bafti, Iraj Sharifi, Maryam Taghavi Shirazi +6
    Iranian journal of parasitologyPeer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMCPMC
  4. Nitrile-Based Leishmania Cysteine Protease B Inhibitors with In Vivo Efficacy against Visceral Leishmaniasis
    Jhonatan Santos de Lima, Michele Ferreira da Silva Mela, Juliana Romano Lopes +15
    ACS OmegaPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefDOAJ
  5. Conventional and ITS1 Gene-PCR Studies on Suspected Cutaneous Leishmaniasis Patients Referred to Different Public Health Hospitals in Quetta, Pakistan.
    Asia Ali Mohsin, Mahrukh Naseem, Imran Taj +3
    Iranian journal of parasitologyPeer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMCPMC
BibTeX
@misc{chari2026detection,
  title = {{PCR Detection and Species Identification of Leishmania in Microscopy-Negative Smears from Suspected Cutaneous Leishmaniasis in Iran}},
  author = {F. Yadollahzadeh Chari and M. Fakhar},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.17.26363305},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.17.26363305v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - PCR Detection and Species Identification of Leishmania in Microscopy-Negative Smears from Suspected Cutaneous Leishmaniasis in Iran
AU  - F. Yadollahzadeh Chari
AU  - M. Fakhar
PY  - 2026
DA  - 2026/09/17
PB  - medRxiv
DO  - 10.64898/2026.09.17.26363305
UR  - https://www.medrxiv.org/content/10.64898/2026.09.17.26363305v1
AB  - BackgroundDirect microscopy remains a practical first-line test for cutaneous leishmaniasis (CL), but it can miss infections when parasite numbers are low or lesions are chronic. We evaluated whether PCR could detect and identify Leishmania in Giemsa-stained smears that had already been reported as microscopy-negative.  MethodsWe retrospectively analyzed 131 microscopy-negative smears from patients with clinically suspected CL who attended health-center laboratories in Gonbad-e-Qabus and Torbat-e-Jam, Iran, between March 2013 and February 2015. DNA was recovered from the stained slides by phenol-chloroform-isoamyl alcohol extraction. kDNA PCR was used for molecular detection and species identification.  ResultsLeishmania DNA was detected in 34 of 131 microscopy-negative samples (25.9%; exact 95% CI, 18.7%-34.3%). Twenty-three positive samples (67.6%) were identified as L. major and 11 (32.4%) as L. tropica. All L. major-positive samples came from Gonbad-e-Qabus, whereas all L. tropica-positive samples came from Torbat-e-Jam. Most PCR-positive lesions (27/34, 79.4%) were chronic, secondarily infected, and/or clinically atypical. In a small laboratory verification panel, all 10 microscopy-positive smears were PCR-positive and all 10 non-leishmanial dermatosis controls were PCR-negative.  ConclusionsAbout one in four clinically suspected cases with a negative smear still had detectable Leishmania DNA. PCR of previously stained slides can therefore provide useful second-line confirmation and species information, especially when lesions are chronic or atypical. The small control panel supports assay performance in the study laboratory but is not large enough to provide precise estimates of clinical sensitivity or specificity.
ER  -